|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-10-1
|
|
pubmed:abstractText |
Rash is the most frequent adverse event associated with nevirapine. The use of prednisone has been controversial in this setting. A double-blind placebo-controlled study was performed to evaluate its efficacy in nevirapine-induced rash prevention.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1525-4135
|
|
pubmed:author |
pubmed-author:BlancoJ LJL,
pubmed-author:BoiuSS,
pubmed-author:De MiguelVV,
pubmed-author:DomingoPP,
pubmed-author:ForceLL,
pubmed-author:GESIDA 09/99 Study Group,
pubmed-author:GonzálezAA,
pubmed-author:KnobelHH,
pubmed-author:LocuturaJJ,
pubmed-author:MárquezMM,
pubmed-author:MiróJ MJM,
pubmed-author:RiveroAA,
pubmed-author:SandTT
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
14-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11579272-Adult,
pubmed-meshheading:11579272-Double-Blind Method,
pubmed-meshheading:11579272-Drug Hypersensitivity,
pubmed-meshheading:11579272-Exanthema,
pubmed-meshheading:11579272-Female,
pubmed-meshheading:11579272-Humans,
pubmed-meshheading:11579272-Male,
pubmed-meshheading:11579272-Middle Aged,
pubmed-meshheading:11579272-Nevirapine,
pubmed-meshheading:11579272-Placebos,
pubmed-meshheading:11579272-Prednisone,
pubmed-meshheading:11579272-Reverse Transcriptase Inhibitors
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 study.
|
|
pubmed:affiliation |
Department of Internal Medicine-Infectious Diseases, Hospital del Mar, Barcelona, Spain. hernando@intercom.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
